1. Hawkins T. Understanding and managing the adverse effects of antiretroviral therapy. Antivir Res. 2010;85:201–9.
2. Joint United Nations Programme on HIV/AIDS (UNAIDS). Global report: UNAIDS report on the global AIDS epidemic 2013. Available at: http://www.unaids.org/sites/default/files/en/media/unaids/contentassets/documents/epidemiology/2013/gr2013/UNAIDS_Global_Report_2013_en.pdf.
3. Mehta U. Pharmacovigilance: the devastating consequences of not thinking about adverse drug reactions. Contin Med Educ. 2011;29(6):247–2251.
4. World Health Organization. The safety of medicines in public health programmes: pharmacovigilance an essential tool. 2006. Available at http://www.who.int/medicines/areas/quality_safety/safety_efficacy/Pharmacovigilance_B.pdf.
5. Shubber Z, Calmy A, Andrieux-Meyer I, Vitoria M, Renaud_Thery F, Shaffer N, et al. Adverse events associated with nevirapine and efavirenz-based first-line antiretroviral therapy: a systematic review and meta-analysis. AIDS. 2013;27:1403–12.